The Duckhorn Portfolio: The Wine Could Be Tastier Than The Stock
Summary
- Today, we put fine wine purveyor The Duckhorn Portfolio in the spotlight for the first time.
- The company saw 10%-plus revenue growth in FY2022 as it grows market share in the luxury segment.
- Despite that, the shares are down nearly 30% this year, and the stock saw some notable insider selling this spring.
- Looking for a portfolio of ideas like this one? Members of The Busted IPO Forum get exclusive access to our subscriber-only portfolios. Learn More »
Rob Kim/Getty Images Entertainment
"Accept what life offers you and try to drink from every cup. All wines should be tasted; some should only be sipped, but with others, drink the whole bottle." - Paulo Coelho
Today, we take our first look at The Duckhorn Portfolio (NYSE:NAPA). I have enjoyed the wine from this Napa Valley producer but have never done research into the company. An analysis follows below.
Seeking Alpha
Company Overview:
The Duckhorn Portfolio is headquartered just outside of Santa Rosa, CA. The company produces and offers wines under a portfolio of brands, including Duckhorn Vineyards, Decoy, Goldeneye, Paraduxx, Migration, Canvasback, Calera, Kosta Browne, Greenwing, and Postmark directly to distributors, and directly to retail accounts and consumers. The price point of these wines is roughly $15 to $200 a bottle as the company is focused on the luxury segment of the wine industry.
September Company Presentation
The stock currently trades around $14.50 a share and sports an approximate market capitalization of $1.7 billion. The firm operates on a fiscal year that ends on June 30.
September Company Presentation
The company plans to grow its top line by gaining market share, increasing its direct-to-consumer or DTC sales, and expand its existing wholesale channel distribution. As well as to continue to expand their wine offerings.
September Company Presentation
Fourth Quarter Results:
The company posted fourth quarter numbers on Sept. 28. The Duckhorn Portfolio posted a GAAP profit of a nickel a share, four cents below expectations. Net income was $5.4 million for the quarter, compared to $7.4 million in the year-ago period. Revenues rose 10% from the same period a year ago to $78 million, largely in line with the consensus. Sales were powered by 7.1% volume growth and an average 2.9% price increase.
September Company Presentation
Both adjusted gross profit and EBITDA grew at a nice clip during the quarter as well. Adjusted EBITDA for the quarter increased just over 21% to $22.3 million compared to 4Q2021. For the 52-week period as of July 31, the luxury wine segment in this country grew at 3.5% compared with a negative 4.5% for overall wine sales. The company's product portfolio was the fastest-growing supplier of the top 15 luxury wine suppliers on both the dollar and volume growth basis during the quarter.
September Company Presentation
For the full year 2022, revenues rose nearly 11% to just over $372 million. The company booked 62 cents a share of profit in FY2022. Management sees slightly slower sales growth in FY2023 and projects earnings will be flat or have a modest gain.
September Company Presentation
Analyst Commentary and Balance Sheet:
Since fourth quarter results were posted, five analyst firms including Jefferies and Wedbush have reissued or initiated Buy ratings on NAPA. Two of these contain slight downward price target revisions. Price targets proffered range from $18 to $23 a share. Both JPMorgan ($18 price target) and Barclays ($17 price target) have maintained Hold/Neutral ratings on the stock.
Approximately five percent of the outstanding float of this stock is currently held short. Insiders were frequent sellers of the stock this spring, disposing of approximately $4 million in aggregate between April and the first day of July. A beneficial owner dumped five million shares at $19.25 a piece on July 11 as well. The company ended FY2022 with just over $3 million in cash and marketable securities against just over $210 million worth of long-term debt. This gave the company a leverage ratio of 1.8x net debt.
Verdict:
The current analyst firm consensus has the company earning 62 cents a share in FY2023 as revenues improve nearly 7% to just under $400 million. EPS would be flat with FY2022 in this projection. For FY2024, they see earnings rising 10% while sales increase in the high-single digits.
It's hard to get to a buy recommendation on NAPA at these trading levels. The stock goes for north of 20 times forward earnings even as analysts see flat earnings growth this year on mid-single-digit sales growth. The company also has a decent amount of debt, and there was a good slug of insider sales during the spring and early summer.
In addition, consumers will continue to cut back and trade down in 2023, hardly a conducive environment for a high-end wine purveyor. They have little choice given the personal savings rate has sunk to 3.7%, the lowest level since 2008. The average consumer also has lost nearly 6% of their buying power to inflation since the start of 2021 and average real wages have fallen for 18 straight months now.
In conclusion, an investor might be better off picking up one of the company's bottles of wine than buying its shares at the current stock price.
"I cook with wine, sometimes I even add it to the food." - W.C. Fields
Author's note: I present and update my best small-cap Busted IPO stock ideas only to subscribers of my exclusive marketplace, The Busted IPO Forum. Try a free 2-week trial today by clicking on our logo below!
This article was written by
The Busted IPO Forum founded by Bret Jensen, is a hypothetical $200K portfolio built of stocks that have been public for 18 months to five years that are significantly under their offering price. Many times after the initial analyst hyperbole has died and lockups have expired, these same companies can be had for .30 to .50 cents on the dollar from when the shares went public. As lucrative as this niche has been for my portfolio over the years, a service or newsletter has not existed that covered this segment of the market -- until now! The goal in creating the Busted IPO Forum is to build a portfolio of 15-20 small cap and mid cap busted IPOs which consistently outperform the Russell 2000 over time. As of 07/02/2021 our model portfolio has generated an overall return of 73.84% substantially above the 52.37% gain from the Russell 2000 over the same time frame.
• • •
Specializing in profiling high beta sectors, Bret Jensen founded and also manages The Biotech Forum, The Insiders Forum, and the Busted IPO Forum model portfolios. Finding “gems” in the biotech and small-cap stock sectors, these highly volatile spaces proven hugely successful have empowered Bret Jensen's own investing portfolio.
• • •
Learn more about Bret Jensen's Marketplace offerings:
Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.